A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C). [electronic resource]
Producer: 20120213Description: 1131-7 p. digitalISSN:- 1432-1041
- Citalopram -- therapeutic use
- Cross-Over Studies
- Double-Blind Method
- Female
- Gene Frequency
- Genetic Association Studies
- Humans
- Male
- Neuralgia -- drug therapy
- Polymorphism, Single Nucleotide
- Receptor, Serotonin, 5-HT2C -- genetics
- Selective Serotonin Reuptake Inhibitors -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.